BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1127 related articles for article (PubMed ID: 28409830)

  • 21. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Al Hajeri A; Fedorowicz Z
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD006111. PubMed ID: 26869149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Riddington C; De Franceschi L
    Cochrane Database Syst Rev; 2002; (4):CD003426. PubMed ID: 12519597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitamin D supplementation for sickle cell disease.
    Soe HHK; Abas AB; Than NN; Ni H; Singh J; Said ARBM; Osunkwo I
    Cochrane Database Syst Rev; 2020 May; 5(5):CD010858. PubMed ID: 32462740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010155. PubMed ID: 26684281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Singh PC; Ballas SK
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003426. PubMed ID: 17943791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD004448. PubMed ID: 32977351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate supplementation in people with sickle cell disease.
    Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004448. PubMed ID: 29446825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.
    van Zuuren EJ; Fedorowicz Z
    Cochrane Database Syst Rev; 2013 Jun; (6):CD010155. PubMed ID: 23760785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for treating neuropathic pain in people with sickle cell disease.
    Asnani MR; Francis DK; Brandow AM; Hammond Gabbadon CE; Ali A
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012943. PubMed ID: 31273755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2015 Apr; (4):CD004448. PubMed ID: 25844571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.
    Asnani MR; Quimby KR; Bennett NR; Francis DK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011175. PubMed ID: 27711980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant supplementation for sickle cell disease.
    Bolarinwa AB; Oduwole O; Okebe J; Ogbenna AA; Otokiti OE; Olatinwo AT
    Cochrane Database Syst Rev; 2024 May; 5(5):CD013590. PubMed ID: 38775255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2010 Oct; (10):CD004448. PubMed ID: 20927735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laser therapy for retinopathy in sickle cell disease.
    Myint KT; Sahoo S; Thein AW; Moe S; Ni H
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD010790. PubMed ID: 36508693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
    Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O; Cohall DH
    Cochrane Database Syst Rev; 2013 Jan; (1):CD004448. PubMed ID: 23440792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc supplements for treating thalassaemia and sickle cell disease.
    Swe KM; Abas AB; Bhardwaj A; Barua A; Nair NS
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009415. PubMed ID: 23807756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.